Tislelizumab

Tislelizumab
Fab fragment of tislelizumab (green) binding the extracellular domain of PD-1 (pale pink). From PDB entry 7BXA
Monoclonal antibody
TypeWhole antibody
SourceHumanized
TargetPD-1
Clinical data
Trade namesTevimbra
Other namesBGB-A317, tislelizumab-jsgr
AHFS/Drugs.comMonograph
MedlinePlusa624026
License data
Pregnancy
category
Routes of
administration		Intravenous
Drug classAntineoplastic agent
ATC code
Legal status
Legal status
Identifiers
CAS Number
DrugBank
ChemSpider
  • none
UNII
KEGG

Tislelizumab, sold under the brand name Tevimbra among others, is a humanized monoclonal antibody directed against programmed death receptor-1.[3] It is being developed by BeiGene.[6]

Tislelizumab was approved for medical use in China in December 2019,[7] in the European Union in September 2023,[4] and in the United States in March 2024.[8]

Medical uses

In China, tislelizumab is indicated to treat people with classical Hodgkin lymphoma who have received at least two prior therapies;[7] and to treat people with locally advanced or metastatic urothelial carcinoma with PD-L1 high expression whose disease progressed during or following platinum-containing chemotherapy or within twelve months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.[9]

In the EU, tislelizumab is indicated for the treatment of adults with unresectable, locally advanced or metastatic esophageal squamous cell carcinoma after prior platinum-based chemotherapy.[4]

In the US, tislelizumab is indicated for the treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma after prior systemic chemotherapy that did not include a PD-(L)1 inhibitor.[3]

Adverse effects

Adverse effects include anemia, leukopenia, thrombocytopenia, nausea, increased aspartate transaminase (AST), neutropenia, fatigue, decreased appetite, vomiting, musculoskeletal pain, constipation, hypoproteinemia and rash.[10] Fatal events such as respiratory infection or failure, and hepatic injury have been reported.[11]

Adverse events are more common when combined with chemotherapy.[12]

Pharmacokinetics

Phase I clinical trial from 2016 has results suggesting an elimination half-life of 11 to 17 days.[13] A 2021 structural and functional analysis suggests a t1/2 of 238 ± 32 minutes, 30- to 80-times higher than pembrolizumab and nivolumab.[14]

History

Phase I trials began in the US and Australia in June 2015.[15] Some early results were announced in July 2016.[16][13]

A phase II clinical trial for urothelial cancer started in China in 2017.[17]

Tislelizumab "demonstrated efficacy and tolerability" in a multicenter phase III trial for advanced hepatocellular carcinoma started in January 2018.[6][18]

Society and culture

Names

Tislelizumab is the international nonproprietary name.[19]

References

  1. ^ a b "Tevimbra (tislelizumab)". Therapeutic Goods Administration (TGA). 28 June 2024. Retrieved 7 July 2024.
  2. ^ "Tevimbra (Beigene Aus Pty Ltd)". Therapeutic Goods Administration (TGA). 1 July 2024. Retrieved 7 July 2024.
  3. ^ a b c "Tevimbra- tislelizumab injection, solution, concentrate". DailyMed. 16 March 2024. Archived from the original on 2 April 2024. Retrieved 2 April 2024.
  4. ^ a b c "Tevimbra EPAR". European Medicines Agency. 4 October 2023. Archived from the original on 28 November 2023. Retrieved 5 October 2023.
  5. ^ "Tevimbra Product information". Union Register of medicinal products. 19 September 2023. Retrieved 1 October 2023.
  6. ^ a b "BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Hepatocellular Carcinoma". BeiGene (Press release). 2 January 2018. Archived from the original on 20 April 2019. Retrieved 20 April 2019 – via GlobeNewswire.
  7. ^ a b "BeiGene scores first China OK with PD-1 — to be manufactured by Boehringer Ingelheim". Endpoints News. 2 January 2020. Archived from the original on 2 July 2020. Retrieved 1 July 2020.
  8. ^ "Novel Drug Approvals for 2024". U.S. Food and Drug Administration (FDA). 29 April 2024. Archived from the original on 30 April 2024. Retrieved 30 April 2024.
  9. ^ "Ploughing through a crowded PD-(L)1 market, BeiGene loads up on promising lung cancer data". Endpoints News. 14 April 2020. Archived from the original on 1 July 2020. Retrieved 1 July 2020.
  10. ^ Zhou Q, Qin Z, Yan P, Wang Q, Qu J, Chen Y (2023). "Immune-related adverse events with severe pain and ureteral expansion as the main manifestations: a case report of tislelizumab-induced ureteritis/cystitis and review of the literature". Frontiers in Immunology. 14: 1226993. doi:10.3389/fimmu.2023.1226993. PMC 10587548. PMID 37869004.
  11. ^ Zhang L, Geng Z, Hao B, Geng Q (January 2022). "Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody". Cancer Control. 29: 10732748221111296. doi:10.1177/10732748221111296. PMC 9358212. PMID 35926155.
  12. ^ Guo Y, Jia J, Hao Z, Yang J (2023). "Tislelizumab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials". Frontiers in Pharmacology. 14: 1172969. doi:10.3389/fphar.2023.1172969. PMC 10318343. PMID 37408759.
  13. ^ a b Desai J, Markman B, Sandhu SK, Gan HK, Friedlander M, Tran B, et al. (20 May 2016). "A phase I dose-escalation study of BGB-A317, an anti-programmed death-1 (PD-1) mAb in patients with advanced solid tumors". Journal of Clinical Oncology. 34 (15_suppl): 3066. doi:10.1200/JCO.2016.34.15_suppl.3066.
  14. ^ Hong Y, Feng Y, Sun H, Zhang B, Wu H, Zhu Q, et al. (March 2021). "Tislelizumab uniquely binds to the CC' loop of PD-1 with slow-dissociated rate and complete PD-L1 blockage". FEBS Open Bio. 11 (3): 782–792. doi:10.1002/2211-5463.13102. PMC 7931243. PMID 33527708.
  15. ^ Clinical trial number NCT02407990 for "Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Subjects With Advanced Tumors" at ClinicalTrials.gov
  16. ^ Martins I (26 July 2016). "Immunotherapy Trial's Early Results Show Activity in Solid Tumors". Immuno-Oncology News. BioNews Inc. Archived from the original on 2 February 2017. Retrieved 24 January 2017.
  17. ^ "BeiGene (BGNE) Commences Pivotal Trial of PD-1 Antibody BGB-A317 in China in Patients with Urothelial Cancer". Archived from the original on 3 July 2020. Retrieved 20 April 2019.
  18. ^ "Novartis announces tislelizumab demonstrated efficacy and tolerability in first-line advanced liver cancer in Phase III trial". Novartis (Press release). Archived from the original on 27 February 2024. Retrieved 2 April 2024.
  19. ^ World Health Organization (2018). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 79". WHO Drug Information. 32 (1). hdl:10665/330941.

Read other articles:

Kowak melayu

Kowak melayu Status konservasi Risiko Rendah (IUCN 3.1)[1] Klasifikasi ilmiah Kerajaan: Animalia Filum: Chordata Kelas: Aves Ordo: Pelecaniformes Famili: Ardeidae Genus: Gorsachius Spesies: G. melanolophus Nama binomial Gorsachius melanolophusRaffles, 1822 Kowak melayu (Gorsachius melanolophus) adalah spesies burung dalam famili Ardeidae. Burung ini tersebar di India, China selatan, Asia Tenggara, dan Filipina. Pada musim dingin, bermigrasi ke selatan sampai ke Sunda Besar....

 

 

Jang Do-yeon

Dalam nama Korean ini, nama keluarganya adalah Jang. Jang Do-yeonLahir10 Maret 1985 (umur 39)Kabupaten Yeonggwang County, Provinsi Jeolla Selatan, Korea SelatanMediaLawakan tunggal, TelevisiTahun aktif2007-sekarangGenreObservasional, Sketsa, Wit, Parodi, Lelucon kasar, Dramatis, Komedi situasiNama KoreaHangul장도연 Alih AksaraJang Do-yeonMcCune–ReischauerChang To-yŏn Jang Do-yeon (lahir 10 Maret 1985), adalah pelawak asal Korea Selatan, menandatangani kontrak dengan KOEN Group.[...

 

 

Guenther House (San Antonio)

Historic house in Texas, United States United States historic placeCarl Hilmar Guenther HouseU.S. National Register of Historic Places Guenther House in 2012Carl Hilmar Guenther HouseShow map of TexasCarl Hilmar Guenther HouseShow map of the United StatesLocation205 E. Guenther St., San Antonio, TexasCoordinates29°24′41″N 98°29′44″W / 29.41139°N 98.49556°W / 29.41139; -98.49556Arealess than one acreBuilt1880 (1880)Architectural styleVernacular Art...

العلاقات الإسواتينية الجيبوتية

العلاقات الإسواتينية الجيبوتية إسواتيني جيبوتي   إسواتيني   جيبوتي تعديل مصدري - تعديل   العلاقات الإسواتينية الجيبوتية هي العلاقات الثنائية التي تجمع بين إسواتيني وجيبوتي.[1][2][3][4][5] مقارنة بين البلدين هذه مقارنة عامة ومرجعية للدولتين: و�...

 

 

Bayshore Blufflands State Natural Area

State Natural Area in Wisconsin Bayshore Blufflands State Natural AreaPreserve kioskLocation of Bayshore Blufflands State Natural Area in WisconsinLocationDoor, Wisconsin, United StatesCoordinates44°56′5″N 87°23′25″W / 44.93472°N 87.39028°W / 44.93472; -87.39028Area370 acres (150 ha)Established2002Governing bodyWisconsin Department of Natural Resources Bayshore Blufflands State Natural Area is a Wisconsin Department of Natural Resources-designated...

 

 

Walter Coles

American politician For the English cricketer, see Walter Coles (cricketer). For his uncle, see Walter Coles (patriot). Walter ColesMember of the U.S. House of Representativesfrom Virginia's 3rd districtIn officeMarch 4, 1843 – March 3, 1845Preceded byJohn Winston JonesSucceeded byWilliam TredwayMember of the U.S. House of Representativesfrom Virginia's 6th districtIn officeMarch 4, 1835 – March 3, 1843Preceded byThomas DavenportSucceeded byJohn Winsto...

Le Soler

Pour les articles homonymes, voir Soler. Le Soler Mairie du Soler. Blason Administration Pays France Région Occitanie Département Pyrénées-Orientales Arrondissement Perpignan Intercommunalité Perpignan Méditerranée Métropole Maire Mandat Armelle Revel Fourcade 2020-2026 Code postal 66270 Code commune 66195 Démographie Gentilé Solérien, Solérienne Populationmunicipale 7 846 hab. (2021 ) Densité 758 hab./km2 Géographie Coordonnées 42° 40′ 58″ n...

 

 

Coppa di Francia 2019-2020

Disambiguazione – Se stai cercando altri significati, vedi Coppa di Francia 2019-2020 (disambigua). Coupe de France 2019-2020 Competizione Coppa di Francia Sport Calcio Edizione 103ª Organizzatore FFF Luogo  Francia Risultati Vincitore  Paris Saint-Germain(13º titolo) Secondo  Saint-Étienne Semi-finalisti  Olympique Lione Rennes Statistiche Miglior marcatore Pablo Sarabia (7) Incontri disputati 63 Gol segnati 201 (3,19 per incontro) Cronologia della co...

 

 

B

  此條目介紹的是拉丁字母中的第2个字母。关于其他用法，请见「B (消歧义)」。   提示：此条目页的主题不是希腊字母Β、西里尔字母В、Б、Ъ、Ь或德语字母ẞ、ß。 BB b(见下)用法書寫系統拉丁字母英文字母ISO基本拉丁字母（英语：ISO basic Latin alphabet）类型全音素文字相关所属語言拉丁语读音方法 [b][p][ɓ](适应变体)Unicode编码U+0042, U+0062字母顺位2数值 2歷史發...

Pierre Morency

Pierre MorencyBorn (1942-05-08) 8 May 1942 (age 81)Lauzon, Quebec Pierre Morency, OC CQ (born 8 May 1942) is a French Canadian writer, poet and playwright. Life Born in Lauzon, Quebec, he received a Bachelor of Arts degree from the Collège de Lévis in 1963 and a teaching diploma from the Université Laval in 1966. Awards In 2002, Morency was made an officer of the Order of Canada and is considered one of the most important poets of his generation, drawing his inspiration from the v...

 

 

Lymphedema

Medical conditionLymphedemaOther namesLymphoedema, lymphatic obstruction, lymphatic insufficiencyLower extremity lymphedemaSpecialtyVascular medicine, Rheumatology,[1] Physical medicine and rehabilitation, General surgery, Plastic surgeryDiagnostic methodBased on symptoms[2]Differential diagnosisLipodystrophy, venous insufficiency[2] Lymphedema, also known as lymphoedema and lymphatic edema, is a condition of localized swelling caused by a compromised lymphatic system....

 

 

Філософія

Частина серії проФілософіяLeft to right: Plato, Kant, Nietzsche, Buddha, Confucius, AverroesПлатонКантНіцшеБуддаКонфуційАверроес Філософи Епістемологи Естетики Етики Логіки Метафізики Соціально-політичні філософи Традиції Аналітична Арістотелівська Африканська Близькосхідна іранська Буддій�...

Elizabeth Ponsonby

English aristocrat William Acton, Margot Bendir, Elizabeth Ponsonby, Harry Melville, and Babe Plunket-Greene at David Tennant's party 1928 Hon. Elizabeth Ponsonby (28 December 1900 – 31 July 1940) was an English aristocrat who was a prominent member of the Bright Young Things, well-connected socialites who featured heavily in the contemporary tabloid press for what were perceived to be their hedonistic antics. The daughter of Arthur Ponsonby, diplomat and Foreign Office ministe...

 

 

Turkey (bird)

North American genus of large birds This article is about all species of turkey. For its meat, see Turkey meat. For other uses, see Turkey (disambiguation) § Other common meanings. TurkeyTemporal range: 23–0 Ma PreꞒ Ꞓ O S D C P T J K Pg N Early Miocene – Recent A male wild turkey strutting Scientific classification Domain: Eukaryota Kingdom: Animalia Phylum: Chordata Class: Aves Order: Galliformes Family: Phasianidae Subfamily: Phasianinae Tribe: Tetraonini Genus: Meleagris...

 

 

1932 United States presidential election in Indiana

Election in Indiana Main article: 1932 United States presidential election 1932 United States presidential election in Indiana ← 1928 November 8, 1932[1] 1936 → All 14 Indiana votes to the Electoral College   Nominee Franklin D. Roosevelt Herbert Hoover Party Democratic Republican Home state New York California Running mate John Nance Garner Charles Curtis Electoral vote 14 0 Popular vote 862,054 677,184 Percentage 54.67% 42.94% County Re...

1863 Swiss federal election

This article is part of a series on thePolitics of Switzerland Constitution Human rights Federal Council Members (by seniority) Beat Jans Guy Parmelin Ignazio Cassis Viola Amherd (President) Karin Keller-Sutter (Vice President) Albert Rösti Élisabeth Baume-Schneider Federal Chancellor Viktor Rossi Federal administration Federal Assembly Council of States (members) National Council (members) Political parties Elections Voting Elections 1848 1851 1854 1857 1860 1863 1866 1869 1872 1875 1878 1...

 

 

Bomba de nêutrons

Esta página cita fontes, mas que não cobrem todo o conteúdo. Ajude a inserir referências (Encontre fontes: ABW  • CAPES  • Google (N • L • A)). Conteúdo não verificável pode ser removido. (Setembro de 2017) A bomba de neutrões (português europeu) ou nêutrons (português brasileiro) é a última variante da bomba atômica. Em geral, é um dispositivo termonuclear pequeno, com corpo de níquel ou cromo, onde os nêutrons ge...

 

 

Associazione Sportiva Frosinone 1987-1988

Voce principale: Frosinone Calcio. Associazione Sportiva FrosinoneStagione 1987-1988Sport calcio Squadra Frosinone Allenatore Alberto Mari Presidente Mario Iannarilli Serie C19º posto nel girone B Maggiori presenzeCampionato: Berardi, Cari, Cristiano, Davato, Malaman (33) Miglior marcatoreCampionato: Berardi (7) 1986-1987 1988-1989 Si invita a seguire il modello di voce Questa pagina raccoglie le informazioni riguardanti l'Associazione Sportiva Frosinone nelle competizioni ufficiali de...

The Golden Chance

The Golden ChanceIklan surat kabarSutradaraCecil B. DeMilleProduserCecil B. DeMilleDitulis olehCecil B. DeMilleJeanie MacphersonPemeranCleo RidgelySinematograferAlvin WyckoffPenyuntingCecil B. DeMilleDistributorParamount PicturesTanggal rilis 30 Desember 1915 (1915-12-30) Durasi74 menitNegaraAmerika SerikatBahasaBisu Intertitel Inggris The Golden Chance The Golden Chance adalah sebuah film drama Amerika Serikat tahun 1915 garapan Cecil B. DeMille. Sebuah cetakan dari film tersebut disimp...

 

 

Marcus Marius (quaestor 76 BC)

Roman quaestor and general Marcus Marius was a quaestor of the Roman Republic in 76 BC[1] and proquaestor under Quintus Sertorius's government in exile in Spain. Marius was sent by Sertorius to Mithradates of Pontus as an advisor and military commander in the Third Mithridatic War. He is named as or more likely confused with a Varius in Appian.[2] Family and political connections No connection has been established between this Marius and Gaius Marius or the other contemporary ...